Viralgen and Trogenix to progress gene therapy for glioblastoma
Viralgen has partnered biotech company Trogenix, aiming to accelerate the development of gene therapy for glioblastoma.
Viralgen has partnered biotech company Trogenix, aiming to accelerate the development of gene therapy for glioblastoma.
What's Your Reaction?
